SLC6A3 and Parkinson disease: In contrast, C. butyricum‐GLP‐1 administration increased TH and DAT levels and decreased α‐syn aggregation, suggesting that C. butyricum‐GLP‐1 could prevent MPTP‐induced neuropathologic changes in PD mice (Figure 3).